Premium
Biohaven Ltd (BHVN)
NYSE
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on discovering and developing therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, immunology, and disease-related biology, including rare disorders. Biohaven Ltd is a clinical-stage biopharmaceutical company focused on discovering and developing therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, immunology, and disease-related biology, including rare disorders.
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -5.66 | -15.8899494666 | 35.62 | 38.23 | 28.01 | 1147666 | 34.42555046 | CS |
| 4 | -7.81 | -20.6777866031 | 37.77 | 44.280313 | 28.01 | 893223 | 38.08812659 | CS |
| 12 | -13.15 | -30.5033634887 | 43.11 | 44.55 | 28.01 | 1009419 | 37.96185283 | CS |
| 26 | -8.2 | -21.4884696017 | 38.16 | 55.7 | 28.01 | 1004331 | 42.94703005 | CS |
| 52 | -21.54 | -41.8252427184 | 51.5 | 62.21 | 26.8 | 1110038 | 42.64359492 | CS |
| 156 | -84.8 | -73.8933426281 | 114.76 | 152.56 | 7.1 | 1168402 | 51.54480905 | CS |
| 260 | -17.46 | -36.8199072121 | 47.42 | 152.56 | 7.1 | 954672 | 60.44415559 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
